Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Regenerative Processing Plant, LLC
WARNING LETTER
•Regenerative Processing Plant, LLC•June 30, 2023

Regenerative Processing Plant, LLC – FDA Warning Letter, Jun 30, 2023

Record Details

The FDA issued a Warning Letter to Regenerative Processing Plant, LLC (RPP) following an inspection from June 20-30, 2023. The inspection revealed significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals (21 CFR parts 210 and 211) in the manufacturing of Regener-Eyes® PRO and Regener-Eyes® LITE Ophthalmic Solutions. These products, distributed nationwide, are deemed adulterated under section 501(a)(2)(B) of the FD&C Act.

Furthermore, Regener-Eyes® PRO and Regener-Eyes® LITE are classified as unapproved new drugs under section 505(a) and misbranded under sections 502(a) and 502(ee) of the FD&C Act. The products do not conform to OTC Monograph M018 for ophthalmic demulcents, specifically regarding the unpermitted active ingredient "Tonicity Solution Sodium Chloride" and missing required labeling warnings. Misleading claims on labeling and websites, such as "FDA registered OTC drug" and "in full compliance with the FDA," contribute to misbranding.

CGMP violations include: 1. Failure to validate aseptic processes, evidenced by contaminated media fill batches and inadequate incubation/examination of filled units. 2. Inadequate environmental monitoring, lacking defined alert/action levels and growth promotion testing for media

Company
Regenerative Processing Plant, LLC
Inspection date
June 30, 2023
Product type
Biologics
Office
Center for Biologics Evaluation and Research
People
  • Michael W. Roosevelt (Program Division Director)
  • Melissa J. Mendoza (Director)
  • Jill P. Furman (Director)
View Company Profile

ID · e8bc4905-c760-4d7e-9d0d-8b29688591a9

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121.U.S.C. 355(a)21 U.S.C. 352(a)21 U.S.C. 352(ee)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)21 U.S.C. 36021 CFR 207.1

Full citation text and observation details available on the Dashboard.

Other documents for Regenerative Processing Plant, LLC
  • 483 - 2023-06-30June 30, 2023

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Regenerative Processing Plant, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.